• Rethinking enhancement substance use: A critical discourse studies approach

    2021
    Rebecca, Askew Lisa, Williams

  • Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach

    2021
    Igor, Magaraggia Zilla, Kuiperes Rudy, Schreiber

  • United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020

    2022
    Brian S., Barnett Sloane E., Parker Jeremy, Weleff

  • Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field

    2022
    Dimitri, Daldegan-Bueno Vanessa Manchim, Favaro Paulo Rogério, Morais Alessandra, Sussulini Maria Gabriela Menezes, Oliveira

  • Psychedelic drugs for psychiatric disorders

    2022
    Sabrina Correa, Da Costa Tyler, Oesterle Teresa A., Rummans Elliot, Richelson Mark, Gold

  • The illusion of knowledge in the emerging field of psychedelic research

    2022
    Genís, Ona Maja, Kohek José Carlos, Bouso

  • The future of hallucination research: Can hallucinogens and psychedelic drugs teach us anything?

    2023
    Flavie, Waters

  • Psychedelic discourses: A qualitative study of discussions in a Danish online forum

    2023
    Søren, Holm Margit Anne, Petersen Oskar, Enghoff Morten, Hesse

  • LSD and Ayahuasca in Argentina: The Pioneering Work of a Psychoanalyst in the 1950s : Luisa Rebeca Gambier de Álvarez de Toledo.

    2023
    Zoé, Dubus

  • The Urban Experience of Ayahuasca: Landscapes of Contemporary Subjectivities.

    2011
    Clara, Novaes
  • 3387 papers
  • « Previous
  • Next »